AstraZeneca PLC (AZN.L) News Headlines

▮ More

Date

Headline

11/24/2020 1:55:02 AM AZN's COVID Shot 70% Effective On Average, ARQT Aces Scalp Psoriasis Study, BLRX' BLAST Fizzles

11/23/2020 3:01:36 AM Astrazeneca Says Covid Vaccine 70% Effective; To Seek Early Approval

11/23/2020 2:05:57 AM AstraZeneca Says AZD1222 Vaccine Meets Primary Efficacy Endpoint In Preventing COVID-19

11/20/2020 2:08:31 AM AstraZeneca: FDA Approves New Dosing Option For Imfinzi - Quick Facts

11/20/2020 2:03:04 AM AstraZeneca Says Imfinzi Approved In US For Less-frequent, Fixed-dose Use

11/20/2020 1:46:37 AM AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B

11/19/2020 9:11:24 AM Oxford-AstraZeneca Covid-19 Vaccine Shows Good Immune Response In Older People

11/19/2020 7:29:36 AM AstraZeneca To Present New Research Aimed At Addressing Key Unmet Needs Facing Patients With Blood Cancers At ASH

11/19/2020 7:24:48 AM Oxford-AstraZeneca COVID-19 Vaccine Candidate Shows Strong Immune Response In Older Adults

11/19/2020 6:52:58 AM Oxford-AstraZeneca Covid-19 Vaccine Shows Good Immune Response In Older People

11/16/2020 2:45:14 AM COVID-19 Vaccines - The Blues And Ease Of Cold Storage

11/13/2020 10:03:45 AM AZN : Four Out Of Five Patients With Heart Failure With Reduced Ejection Fraction Eligible For Treatment With FARXIGA

11/13/2020 2:17:00 AM AZN's Repurposed COVID-19 Drug Fails, NAVB On Watch, CVAC Rallies On Storage Advantage Of CVnCoV

11/10/2020 5:38:39 AM Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN…

11/10/2020 3:16:20 AM AstraZeneca, Amgen Report Positive Results From Tezepelumab Trial In Severe Asthma

11/10/2020 2:13:52 AM AstraZeneca And Amgen Announce Positive Results From NAVIGATOR Phase III Trial Of Tezepelumab

11/9/2020 2:45:08 AM AstraZeneca: EU Approves Calquence To Treat Chronic Lymphocytic Leukaemia

11/9/2020 2:10:15 AM AstraZeneca Says Calquence Approved In EU For Chronic Lymphocytic Leukaemia

11/6/2020 2:32:02 AM AstraZeneca: Brilinta Approved In US To Reduce Risk In Ischaemic Stroke

11/6/2020 2:15:30 AM AstraZeneca Says Brilinta Approved In US To Reduce The Risk Of Stroke

Astrazeneca Plc (AZN.L)